-
New drug for multiple myeloma! Tj202 / mor202, the first case of clinical trial in mainland China, was administered
Time of Update: 2020-01-06
January 6, 2020 / Biovalley BIOON / - Tianjing Biotechnology (Shanghai) Co., Ltd (hereinafter referred to as "Tianjing biology") recently announced that tj202 / mor202, the innovative human CD38 antib
-
The State Food and Drug Administration just released this document
Time of Update: 2019-06-26
On June 25, the State Food and Drug Administration issued a notice saying that in order to implement the requirements of the notice on issues related to the review and approval of clinically urgently
-
Summary of the results of the third batch of quality sampling in Zhejiang Province
Time of Update: 2019-06-04
Recently, the drug sampling action carried out by Zhejiang food and drug administration has ended, and the third drug quality announcement in 2019 has been issued There are 36 varieties and 53 batches
-
Amlodipine besylate tablet of Yabao Pharmaceutical Co., Ltd. has been appraised, becoming the first one in Shanxi Province
Time of Update: 2019-03-14
On March 14, Yabao pharmaceutical announced that amlodipine besylate tablets declared by the company had obtained the approval document for supplementary application of drugs approved and issued by th
-
Progress & Summary: The pass rate of consistency evaluation 289 is only 7.96%; the latest three companies have passed the evaluation, Shanghai Pharmaceutical, Yuekang Pharmaceutical, Shandong
Time of Update: 2018-12-26
As of December 25, a total of 133 products have passed (or deemed to have passed) conformity assessment, involving 66 varieties, of which 47 products have passed 289 catalogue, involving 23 varieties,
-
FDA Approves the first new drug for smallpox treatment
Time of Update: 2018-07-16
Recently, the U.S Food and Drug Administration (FDA) approved SIgA technologies' new drug tpoxx (teovirimat), the first drug to treat smallpox, to fight bioterrorism It is reported that tpoxx was join
-
[exclusive] list of global rheumatic treatment drugs in 2022
Time of Update: 2017-12-25
Rheumatoid arthritis (RA) is a chronic, progressive, multiple, invasive autoimmune disease, with synovitis and extraarticular lesions as the main clinical manifestations There was no significant regio
-
Actr: another new drug declared by FDA
Time of Update: 2017-09-22
Source: CPHI Pharma online 2017-09-22 on August 23, 2017, the U.S Food and Drug Administration (FDA) approved another ind application of the actr therapy of unum therapeutics, which is combined with t
-
"Bright spot" of performance growth of traditional Chinese medicine enterprises
Time of Update: 2017-07-31
[market analysis of chinapharma.com] according to the completion of main economic indicators of the pharmaceutical industry in 2016, the main business income of the traditional Chinese medicine drink
-
Drug examination center held a retreat on guiding principles for clinical research of new Chinese Medicine
Time of Update: 2017-05-24
Source: CDE 2017-05-24 in order to speed up the establishment of the technical standard system of traditional Chinese medicine in line with the characteristics of traditional Chinese medicine and prom
-
New rapid approval scheme for potential drugs in Europe
Time of Update: 2016-03-09
Source: on March 9, 2016, the European regulatory authorities launched a new plan to accelerate the approval of promising new drugs to address unmet medical needs, which will provide a lot of support
-
End of GMP: is there any play in technology transfer
Time of Update: 2016-01-05
Source: pharmaceutical economic news 2016-01-05 is a key time point for GMP certification in 2015-2016 On December 30, 2015, CFDA issued a notice to transfer GMP certification to the Provincial Bureau
-
The United States: patients in the new era of "precision medicine" can't afford high price drugs
Time of Update: 2015-06-16
Source: guangming.com June 16, 2015 according to the report of chinanet.com on June 14, scientists analyzed that drug development has opened the door for the new era of "accurate medicine", but at the
-
Da'an gene: a detection reagent for Ebola virus is currently under development
Time of Update: 2014-08-06
Source: Investment express announced in the afternoon of Daan gene (002030) with poor performance in the morning on August 5, 2014 The company obtained a registration certificate of medical devices is
-
The first biological inhibitor of hereditary angioedema, ruconest, approved by FDA
Time of Update: 2014-07-18
Source: biodicover 2014-7-18 on July 17, 2014, the US Food and Drug Administration (FDA) approved the first recombinant C1 esterase inhibitor, ruconest, a product for the treatment of hereditary angio
